A Cambridge, MA-based personal genomics company has raised $5 million from one investor in a round that could eventually total $20 million, according to a regulatory filing. Launched in 2007 by the famed Harvard geneticist George Church, Knome offers wealthy consumers the chance to have their entire genomes sequenced and analyzed by the company’s scientists. But as prices for such services have plummeted over the last few years, the once-profitable company has struggled to get back in the black.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
